JP Morgan Chase
OMGA

JP Morgan Chase’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

JP Morgan Chase’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-503
Closed -$375 – 7856
2024
Q4 		$375 Hold
503
– – ﹤0.01% 6834
2024
Q3 		$614 Sell
503
-1
-0.2% -$2 ﹤0.01% 6781
2024
Q2 		$1.04K Sell
504
-9,594
-95% -$22.6K ﹤0.01% 6610
2024
Q1 		$36.9K Sell
10,098
-5,699
-36% -$21.9K ﹤0.01% 6044
2023
Q4 		$47.5K Sell
15,797
-10,305
-39% -$20.9K ﹤0.01% 6015
2023
Q3 		$56.1K Buy
26,102
+4,779
+22% +$19.1K ﹤0.01% 5759
2023
Q2 		$119K Buy
21,323
+19,639
+1,166% +$154K ﹤0.01% 5382
2023
Q1 		$10K Buy
1,684
+128
+8% +$891 ﹤0.01% 6123
2022
Q4 		$9K Sell
1,556
-1,224
-44% -$6.87K ﹤0.01% 6063
2022
Q3 		$15K Buy
2,780
+877
+46% +$4.44K ﹤0.01% 5884
2022
Q2 		$7K Sell
1,903
-16,327
-90% -$60.8K ﹤0.01% 6108
2022
Q1 		$113K Buy
18,230
+9,243
+103% +$94.4K ﹤0.01% 5452
2021
Q4 		$102K Buy
8,987
+6,155
+217% +$117K ﹤0.01% 5671
2021
Q3 		$53K Buy
+2,832
New +$54.3K ﹤0.01% 5826

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

JP Morgan Chase's OMGA Position: Q1 2025 in Review

JP Morgan Chase sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 503 shares — an estimated $375 sold.

JP Morgan Chase first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $119K in Q2 2023. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • JP Morgan Chase reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 503 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $375.
  • JP Morgan Chase first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • JP Morgan Chase's Omega Therapeutics, Inc. Common Stock position peaked at $119K in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.